Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction

E. K. Weir, I. F. McMurtry, A. Tucker, J. T. Reeves, R. F. Grover

Research output: Contribution to journalArticlepeer-review

66 Scopus citations


Prostaglandins are naturally occurring substances with powerful vasoactive effects that are released from tissues during hypoxia or ischemia. Several workers have suggested that a prostaglandin may help to mediate the pulmonary vascular pressor response to alveolar hypoxia. To investigate this possibility, the authors have measured the pressor responses to hypoxia before and after prostaglandin synthesis antagonism with meclofenamate in eight anesthetized dogs, two groups of awake calves (n = 10 and n = 5), and nine isolated, perfused rat lungs. In addition, synthesis was inhibited by the use of indomethacin in nine additional dogs. The stability of the pulmonary vascular response to repeated hypoxic challenges was demonstrated in nine other dogs. In each species and with both prostaglandin antagonists, the pulmonary pressor responses to hypoxia were significantly increased rather than reduced. The authors conclude that prostaglandins do not mediate the pulmonary vasoconstriction caused by hypoxia. The consistent increase observed suggests that hypoxic vasoconstriction stimulates prostaglandin synthesis, the net effect of which is pulmonary vasodilatation which opposes the constriction.

Original languageEnglish (US)
Pages (from-to)714-718
Number of pages5
JournalUnknown Journal
Issue number5 (I)
StatePublished - 1976


Dive into the research topics of 'Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction'. Together they form a unique fingerprint.

Cite this